The forecast for diuretic medicine sales in Canada indicates stability from 2024 to 2026 at 0.9% of total sales. Starting in 2027, a slight increase to 1% is expected, maintaining this level through 2028. There were no observed fluctuations or variations between years within this forecast period. In 2023, sales stood at similar levels, establishing a stable market for diuretics. The compound annual growth rate (CAGR) over these five years remains modest due to the small incremental change at the end of the forecast period.
Future trends to watch for include potential market drivers such as an aging population, increasing prevalence of conditions like hypertension, and advancements in drug formulation, which might influence growth beyond the predicted stability.
